Global Preventive Vaccines Market

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity

Global Preventive Vaccines Market

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure.

Highlighted with 111 tables and 87 figures, this 211-page report “Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global preventive vaccines market in every aspect of the classification from perspectives of Vaccine Type, Disease, Administration, Patient, and Region.

Based on Vaccine Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Live/Attenuated Vaccines

• Inactivated Vaccines

• Subunit Vaccines

• Toxoid Vaccines

• Conjugate Vaccines

• mRNA Vaccines

• Recombinant Vector Vaccines

• Other Vaccines

Based on Disease, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Pneumococcal Disease

• Poliovirus

• Hepatitis

• Influenza

• Measles, Mumps, and Rubella (MMR)

• Varicella

• Human Papilloma Virus

• COVID-19

• Other Diseases

By Administration, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Intramuscular Route

• Subcutaneous Route

• Oral Route

• Intravenous Injection

• Other Administration Routes

By Patient, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Pediatric Vaccines

o Pneumococcal

o Measles, Mumps, and Rubella (MMR)

o Varicella

o Hepatitis

o Poliovirus

o Haemophilus Influenzae B (HIB)

o Other Diseases

• Adult Vaccines

o Influenza

o Cervical Cancer

o Hepatitis

o Zoster

o Other Diseases

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)

• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

• South America (Brazil, Chile, Argentina, Rest of South America)

• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)

For each region and country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and the breakdown of each national market by Vaccine Type, Disease, and Administration over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

AstraZeneca plc

Bavarian Nordic A/S

China National Biotec Group Company Ltd.

CSL Ltd.

Daiichi Sankyo Co. Ltd

Emergent BioSolutions Inc.

GlaxoSmithKline plc

Johnson & Johnson

Merck & Co.

Moderna Inc.

Novavax, Inc.

Pfizer Inc.

Sanofi SA

Takeda Pharmaceutical Co. Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

1 Introduction 10

1.1 Industry Definition and Research Scope 10

1.1.1 Industry Definition 10

1.1.2 Research Scope 11

1.2 Research Methodology 14

1.2.1 Overview of Market Research Methodology 14

1.2.2 Market Assumption 15

1.2.3 Secondary Data 15

1.2.4 Primary Data 15

1.2.5 Data Filtration and Model Design 16

1.2.6 Market Size/Share Estimation 17

1.2.7 Research Limitations 18

1.3 Executive Summary 19

2 Market Overview and Dynamics 22

2.1 Market Size and Forecast 22

2.1.1 Impact of COVID-19 on World Economy 24

2.1.2 Impact of COVID-19 on the Market 27

2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 29

2.2 Major Growth Drivers 33

2.3 Market Restraints and Challenges 39

2.4 Emerging Opportunities and Market Trends 42

2.5 Porter’s Fiver Forces Analysis 46

3 Segmentation of Global Market by Vaccine Type 50

3.1 Market Overview by Vaccine Type 50

3.2 Live/Attenuated Vaccines 52

3.3 Inactivated Vaccines 53

3.4 Subunit Vaccines 54

3.5 Toxoid Vaccines 55

3.6 Conjugate Vaccines 56

3.7 mRNA Vaccines 57

3.8 Recombinant Vector Vaccines 58

3.9 Other Vaccines 59

4 Segmentation of Global Market by Disease 60

4.1 Market Overview by Disease 60

4.2 Pneumococcal Disease 62

4.3 Poliovirus 63

4.4 Hepatitis 64

4.5 Influenza 65

4.6 Measles, Mumps, and Rubella (MMR) 66

4.7 Varicella 67

4.8 Human Papilloma Virus 68

4.9 COVID-19 69

4.10 Other Diseases 70

5 Segmentation of Global Market by Administration 71

5.1 Market Overview by Administration 71

5.2 Intramuscular Route 73

5.3 Subcutaneous Route 74

5.4 Oral Route 75

5.5 Intravenous Injection 76

5.6 Other Administration Routes 77

6 Segmentation of Global Market by Patient 78

6.1 Market Overview by Patient 78

6.2 Pediatric Vaccines 80

6.3 Adult Vaccines 82

7 Segmentation of Global Market by Region 84

7.1 Geographic Market Overview 2022-2032 84

7.2 North America Market 2022-2032 by Country 88

7.2.1 Overview of North America Market 88

7.2.2 U.S. 92

7.2.3 Canada 96

7.2.4 Mexico 99

7.3 European Market 2022-2032 by Country 102

7.3.1 Overview of European Market 102

7.3.2 Germany 106

7.3.3 U.K. 109

7.3.4 France 112

7.3.5 Spain 115

7.3.6 Italy 118

7.3.7 Russia 121

7.3.8 Rest of European Market 124

7.4 Asia-Pacific Market 2022-2032 by Country 126

7.4.1 Overview of Asia-Pacific Market 126

7.4.2 Japan 130

7.4.3 China 134

7.4.4 Australia 137

7.4.5 India 140

7.4.6 South Korea 143

7.4.7 Rest of APAC Region 146

7.5 South America Market 2022-2032 by Country 148

7.5.1 Argentina 151

7.5.2 Brazil 154

7.5.3 Chile 157

7.5.4 Rest of South America Market 160

7.6 MEA Market 2022-2032 by Country 161

7.6.1 UAE 164

7.6.2 Saudi Arabia 167

7.6.3 South Africa 170

7.6.4 Other National Markets 173

8 Competitive Landscape 174

8.1 Overview of Key Vendors 174

8.2 New Product Launch, Partnership, Investment, and M&A 177

8.3 Company Profiles 178

AstraZeneca plc 178

Bavarian Nordic A/S 180

China National Biotec Group Company Ltd. 183

CSL Ltd. 185

Daiichi Sankyo Co. Ltd 187

Emergent BioSolutions Inc. 189

GlaxoSmithKline plc 191

Johnson & Johnson 195

Merck & Co. 197

Moderna Inc. 199

Novavax, Inc. 200

Pfizer Inc. 202

Sanofi SA 206

Takeda Pharmaceutical Co. Ltd. 209

RELATED REPORTS 211

List of Tables:

Table 1. Snapshot of Global Preventive Vaccines Market in Balanced Perspective, 2022-2032 20

Table 2. World Economic Outlook, 2021-2031 25

Table 3. World Economic Outlook, 2021-2023 26

Table 4. Scenarios for Economic Impact of Ukraine Crisis 30

Table 5. World Health Spending by Region, $ bn, 2013-2020 38

Table 6. Main Product Trends and Market Opportunities in Global Preventive Vaccines Market 42

Table 7. Global Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 50

Table 8. Global Preventive Vaccines Market by Disease, 2022-2032, $ mn 60

Table 9. Global Preventive Vaccines Market by Administration, 2022-2032, $ mn 71

Table 10. Global Preventive Vaccines Market by Patient, 2022-2032, $ mn 78

Table 11. Global Preventive Vaccines Market: Pediatric Vaccines by Disease, 2022-2032, $ mn 81

Table 12. Global Preventive Vaccines Market: Adult Vaccines by Disease, 2022-2032, $ mn 83

Table 13. Global Preventive Vaccines Market by Region, 2022-2032, $ mn 85

Table 14. Leading National Preventive Vaccines Market, 2022 and 2032, $ mn 87

Table 15. North America Preventive Vaccines Market by Country, 2022-2032, $ mn 90

Table 16. U.S. Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 94

Table 17. U.S. Preventive Vaccines Market by Disease, 2022-2032, $ mn 94

Table 18. U.S. Preventive Vaccines Market by Administration, 2022-2032, $ mn 95

Table 19. Canada Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 97

Table 20. Canada Preventive Vaccines Market by Disease, 2022-2032, $ mn 97

Table 21. Canada Preventive Vaccines Market by Administration, 2022-2032, $ mn 98

Table 22. Mexico Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 100

Table 23. Mexico Preventive Vaccines Market by Disease, 2022-2032, $ mn 100

Table 24. Mexico Preventive Vaccines Market by Administration, 2022-2032, $ mn 101

Table 25. Europe Preventive Vaccines Market by Country, 2022-2032, $ mn 105

Table 26. Germany Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 107

Table 27. Germany Preventive Vaccines Market by Disease, 2022-2032, $ mn 107

Table 28. Germany Preventive Vaccines Market by Administration, 2022-2032, $ mn 108

Table 29. U.K. Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 110

Table 30. U.K. Preventive Vaccines Market by Disease, 2022-2032, $ mn 110

Table 31. U.K. Preventive Vaccines Market by Administration, 2022-2032, $ mn 111

Table 32. France Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 113

Table 33. France Preventive Vaccines Market by Disease, 2022-2032, $ mn 113

Table 34. France Preventive Vaccines Market by Administration, 2022-2032, $ mn 114

Table 35. Spain Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 116

Table 36. Spain Preventive Vaccines Market by Disease, 2022-2032, $ mn 116

Table 37. Spain Preventive Vaccines Market by Administration, 2022-2032, $ mn 117

Table 38. Italy Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 119

Table 39. Italy Preventive Vaccines Market by Disease, 2022-2032, $ mn 119

Table 40. Italy Preventive Vaccines Market by Administration, 2022-2032, $ mn 120

Table 41. Russia Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 122

Table 42. Russia Preventive Vaccines Market by Disease, 2022-2032, $ mn 122

Table 43. Russia Preventive Vaccines Market by Administration, 2022-2032, $ mn 123

Table 44. Preventive Vaccines Market in Rest of Europe by Country, 2022-2032, $ mn 125

Table 45. APAC Preventive Vaccines Market by Country, 2022-2032, $ mn 128

Table 46. Japan Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 132

Table 47. Japan Preventive Vaccines Market by Disease, 2022-2032, $ mn 132

Table 48. Japan Preventive Vaccines Market by Administration, 2022-2032, $ mn 133

Table 49. China Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 135

Table 50. China Preventive Vaccines Market by Disease, 2022-2032, $ mn 135

Table 51. China Preventive Vaccines Market by Administration, 2022-2032, $ mn 136

Table 52. Australia Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 138

Table 53. Australia Preventive Vaccines Market by Disease, 2022-2032, $ mn 138

Table 54. Australia Preventive Vaccines Market by Administration, 2022-2032, $ mn 139

Table 55. India Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 141

Table 56. India Preventive Vaccines Market by Disease, 2022-2032, $ mn 141

Table 57. India Preventive Vaccines Market by Administration, 2022-2032, $ mn 142

Table 58. South Korea Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 144

Table 59. South Korea Preventive Vaccines Market by Disease, 2022-2032, $ mn 144

Table 60. South Korea Preventive Vaccines Market by Administration, 2022-2032, $ mn 145

Table 61. Preventive Vaccines Market in Rest of APAC by Country/Region, 2022-2032, $ mn 147

Table 62. South America Preventive Vaccines Market by Country, 2022-2032, $ mn 150

Table 63. Argentina Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 152

Table 64. Argentina Preventive Vaccines Market by Disease, 2022-2032, $ mn 152

Table 65. Argentina Preventive Vaccines Market by Administration, 2022-2032, $ mn 153

Table 66. Brazil Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 155

Table 67. Brazil Preventive Vaccines Market by Disease, 2022-2032, $ mn 155

Table 68. Brazil Preventive Vaccines Market by Administration, 2022-2032, $ mn 156

Table 69. Chile Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 158

Table 70. Chile Preventive Vaccines Market by Disease, 2022-2032, $ mn 158

Table 71. Chile Preventive Vaccines Market by Administration, 2022-2032, $ mn 159

Table 72. MEA Preventive Vaccines Market by Country, 2022-2032, $ mn 163

Table 73. UAE Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 165

Table 74. UAE Preventive Vaccines Market by Disease, 2022-2032, $ mn 165

Table 75. UAE Preventive Vaccines Market by Administration, 2022-2032, $ mn 166

Table 76. Saudi Arabia Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 168

Table 77. Saudi Arabia Preventive Vaccines Market by Disease, 2022-2032, $ mn 168

Table 78. Saudi Arabia Preventive Vaccines Market by Administration, 2022-2032, $ mn 169

Table 79. South Africa Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 171

Table 80. South Africa Preventive Vaccines Market by Disease, 2022-2032, $ mn 171

Table 81. South Africa Preventive Vaccines Market by Administration, 2022-2032, $ mn 172

Table 82. AstraZeneca plc: Company Snapshot 178

Table 83. AstraZeneca plc: Business Segmentation 179

Table 84. AstraZeneca plc: Product Portfolio 179

Table 85. Bavarian Nordic A/S: Company Snapshot 180

Table 86. Bavarian Nordic A/S: Marketed Products and Pipeline, as of July 2020 181

Table 87. China National Biotec Group Company Ltd.: Company Snapshot 183

Table 88. CSL Ltd.: Company Snapshot 185

Table 89. Daiichi Sankyo Co. Ltd.: Company Snapshot 187

Table 90. Emergent BioSolutions Inc.: Company Snapshot 189

Table 91. GlaxoSmithKline: Company Snapshot 191

Table 92. GlaxoSmithKline: Business Segmentation 192

Table 93. GlaxoSmithKline: Product Portfolio 193

Table 94. GlaxoSmithKline: Revenue, 2018-2020, $ bn 194

Table 95. GlaxoSmithKline: Recent Developments 194

Table 96. Johnson & Johnson: Company Snapshot 195

Table 97. Johnson & Johnson: Business Segments 196

Table 98. Merck & Co., Inc.: Company Snapshot 197

Table 99. Merck & Co., Inc.: Business Segmentation 197

Table 100. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 198

Table 101. Moderna Inc.: Company Snapshot 199

Table 102. Novavax, Inc.: Company Snapshot 200

Table 103. Pfizer Inc.: Company Snapshot 202

Table 104. Pfizer Inc.: Business Segmentation 203

Table 105. Pfizer Inc.: Product Portfolio 204

Table 106. Pfizer Inc.: Revenue, 2018-2020, $ bn 205

Table 107. Pfizer Inc.: Recent Developments 205

Table 108. Sanofi: Company Snapshot 206

Table 109. Sanofi: Business Segmentation 206

Table 110. Sanofi: Revenue, 2018-2020, $ bn 208

Table 111. Takeda Pharmaceutical Co. Ltd.: Company Snapshot 209


List of Figures:

Figure 1. Research Method Flow Chart 14

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17

Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 19

Figure 4. Global Preventive Vaccines Market, 2022-2032, $ mn 22

Figure 5. Development Stages of Preventive Vaccines 23

Figure 6. Impact of COVID-19 on Business 27

Figure 7. Primary Drivers and Impact Factors of Global Preventive Vaccines Market 33

Figure 8. Leading Causes of Death in the World, 2000 and 2019, million 36

Figure 9. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 37

Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 37

Figure 11. Primary Restraints and Impact Factors of Global Preventive Vaccines Market 39

Figure 12. Investment Opportunity Analysis 43

Figure 13. Porter’s Fiver Forces Analysis of Global Preventive Vaccines Market 46

Figure 14. Breakdown of Global Preventive Vaccines Market by Vaccine Type, 2022-2032, % of Revenue 51

Figure 15. Global Addressable Market Cap in 2023-2032 by Vaccine Type, Value ($ mn) and Share (%) 51

Figure 16. Global Preventive Vaccines Market by Vaccine Type: Live/Attenuated Vaccines, 2022-2032, $ mn 52

Figure 17. Global Preventive Vaccines Market by Vaccine Type: Inactivated Vaccines, 2022-2032, $ mn 53

Figure 18. Global Preventive Vaccines Market by Vaccine Type: Subunit Vaccines, 2022-2032, $ mn 54

Figure 19. Global Preventive Vaccines Market by Vaccine Type: Toxoid Vaccines, 2022-2032, $ mn 55

Figure 20. Global Preventive Vaccines Market by Vaccine Type: Conjugate Vaccines, 2022-2032, $ mn 56

Figure 21. Global Preventive Vaccines Market by Vaccine Type: mRNA Vaccines, 2022-2032, $ mn 57

Figure 22. Global Preventive Vaccines Market by Vaccine Type: Recombinant Vector Vaccines, 2022-2032, $ mn 58

Figure 23. Global Preventive Vaccines Market by Vaccine Type: Other Vaccines, 2022-2032, $ mn 59

Figure 24. Breakdown of Global Preventive Vaccines Market by Disease, 2022-2032, % of Sales Revenue 61

Figure 25. Global Addressable Market Cap in 2023-2032 by Disease, Value ($ mn) and Share (%) 61

Figure 26. Global Preventive Vaccines Market by Disease: Pneumococcal Disease, 2022-2032, $ mn 62

Figure 27. Global Preventive Vaccines Market by Disease: Poliovirus, 2022-2032, $ mn 63

Figure 28. Global Preventive Vaccines Market by Disease: Hepatitis, 2022-2032, $ mn 64

Figure 29. Global Preventive Vaccines Market by Disease: Influenza, 2022-2032, $ mn 65

Figure 30. Global Preventive Vaccines Market by Disease: Measles, Mumps, and Rubella (MMR), 2022-2032, $ mn 66

Figure 31. Global Preventive Vaccines Market by Disease: Varicella, 2022-2032, $ mn 67

Figure 32. Global Preventive Vaccines Market by Disease: Human Papilloma Virus, 2022-2032, $ mn 68

Figure 33. Global Preventive Vaccines Market by Disease: COVID-19, 2022-2032, $ mn 69

Figure 34. Global Preventive Vaccines Market by Disease: Other Diseases, 2022-2032, $ mn 70

Figure 35. Breakdown of Global Preventive Vaccines Market by Administration, 2022-2032, % of Sales Revenue 72

Figure 36. Global Addressable Market Cap in 2023-2032 by Administration, Value ($ mn) and Share (%) 72

Figure 37. Global Preventive Vaccines Market by Administration: Intramuscular Route, 2022-2032, $ mn 73

Figure 38. Global Preventive Vaccines Market by Administration: Subcutaneous Route, 2022-2032, $ mn 74

Figure 39. Global Preventive Vaccines Market by Administration: Oral Route, 2022-2032, $ mn 75

Figure 40. Global Preventive Vaccines Market by Administration: Intravenous Injection, 2022-2032, $ mn 76

Figure 41. Global Preventive Vaccines Market by Administration: Other Administration Routes, 2022-2032, $ mn 77

Figure 42. Breakdown of Global Preventive Vaccines Market by Patient, 2022-2032, % of Revenue 79

Figure 43. Global Addressable Market Cap in 2023-2032 by Patient, Value ($ mn) and Share (%) 79

Figure 44. Global Preventive Vaccines Market by Patient: Pediatric Vaccines, 2022-2032, $ mn 80

Figure 45. Global Preventive Vaccines Market by Patient: Adult Vaccines, 2022-2032, $ mn 82

Figure 46. Global Market Snapshot by Region 84

Figure 47. Geographic Spread of Worldwide Preventive Vaccines Market, 2022-2032, % of Sales Revenue 85

Figure 48. Global Addressable Market Cap in 2023-2032 by Region, Value ($ mn) and Share (%) 86

Figure 49. North American Preventive Vaccines Market, 2022-2032, $ mn 89

Figure 50. Breakdown of North America Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue 90

Figure 51. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 91

Figure 52. U.S. Preventive Vaccines Market, 2022-2032, $ mn 93

Figure 53. Canada Preventive Vaccines Market, 2022-2032, $ mn 96

Figure 54. Preventive Vaccines Market in Mexico, 2022-2032, $ mn 99

Figure 55. European Preventive Vaccines Market, 2022-2032, $ mn 103

Figure 56. Breakdown of European Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue 104

Figure 57. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 105

Figure 58. Preventive Vaccines Market in Germany, 2022-2032, $ mn 106

Figure 59. Preventive Vaccines Market in U.K., 2022-2032, $ mn 109

Figure 60. Preventive Vaccines Market in France, 2022-2032, $ mn 112

Figure 61. Preventive Vaccines Market in Spain, 2022-2032, $ mn 115

Figure 62. Preventive Vaccines Market in Italy, 2022-2032, $ mn 118

Figure 63. Preventive Vaccines Market in Russia, 2022-2032, $ mn 121

Figure 64. Preventive Vaccines Market in Rest of Europe, 2022-2032, $ mn 124

Figure 65. Asia-Pacific Preventive Vaccines Market, 2022-2032, $ mn 127

Figure 66. Breakdown of APAC Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue 127

Figure 67. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 129

Figure 68. Preventive Vaccines Market in Japan, 2022-2032, $ mn 131

Figure 69. Preventive Vaccines Market in China, 2022-2032, $ mn 134

Figure 70. Preventive Vaccines Market in Australia, 2022-2032, $ mn 137

Figure 71. Preventive Vaccines Market in India, 2022-2032, $ mn 140

Figure 72. Preventive Vaccines Market in South Korea, 2022-2032, $ mn 143

Figure 73. Preventive Vaccines Market in Rest of APAC, 2022-2032, $ mn 146

Figure 74. South America Preventive Vaccines Market, 2022-2032, $ mn 149

Figure 75. Breakdown of South America Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue 149

Figure 76. Contribution to South America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 150

Figure 77. Preventive Vaccines Market in Argentina, 2022-2032, $ mn 151

Figure 78. Preventive Vaccines Market in Brazil, 2022-2032, $ mn 154

Figure 79. Preventive Vaccines Market in Chile, 2022-2032, $ mn 157

Figure 80. Preventive Vaccines Market in Rest of South America, 2022-2032, $ mn 160

Figure 81. Preventive Vaccines Market in Middle East and Africa (MEA), 2022-2032, $ mn 162

Figure 82. Breakdown of MEA Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue 162

Figure 83. Contribution to MEA 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 163

Figure 84. Preventive Vaccines Market in UAE, 2022-2032, $ mn 164

Figure 85. Preventive Vaccines Market in Saudi Arabia, 2022-2032, $ mn 167

Figure 86. Preventive Vaccines Market in South Africa, 2022-2032, $ mn 170

Figure 87. Growth Stage of Global Preventive Vaccines Industry over the Forecast Period 174

Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Research Programs/Design
Historical Data (2015-2019)
  • Industry Trends
  • Competitive Landscape
  • By Company
  • Expansion
  • Mergers and Acquisitions
  • Market Segment
  • by Type
  • by Application
  • By Regions/ Geography
  • Value Status and Outlook
  • Value for Major Players
  • Market Share
  • Growth Rate
  • Present Situation Analysis
  • Value
  • Market Share
  • Growth Rate
  • Present Situation Analysis
Influencing Factors
  • Market Environment
  • Government Policy
  • Technological Changes
  • Market Risks
  • Market Drivers
  • Growing Demand of Downstream
  • Reduction in Cost
Market Forecast (2021-2026)
  • Overall Size
  • by Type
  • by Application
  • By Regions/Geography
  • Key Data (Value)
  • Market Share
  • Growth Rate
  • CAGR (2021-2026)
Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2021-2026)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2021-2026)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2021-2026)

Frequently asked questions(FAQ's):

Is the Global Preventive Vaccines Market shifting its focus from growth to value?
Recognize the areas along the Global Preventive Vaccines Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
What is the estimated value of the Global Preventive Vaccines Market?
The Global Preventive Vaccines Market is expected to reach a reasonable valuation by 2029; now the market is expected to shift its focus from growth to value.
What does the future hold for the Global Preventive Vaccines Market?
As the shift to value addition continues, companies in the Global Preventive Vaccines Market face the dual challenge of improving interoperability to optimize performance and experience.
What makes the latest Global Preventive Vaccines Market study unique?
The latest version of the Global Preventive Vaccines Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.